drugset / Trial / NCT07843108

Effect of Rimonabant on Hand Function in Patients With Spinal Cord Injury

NCT07843108 ↗

Phase 1/2 Active not recruiting 8 enrolled Sinfatin S.L
NaSingle-groupOpen-labelTreatment

Summary

This is an one arm study to be conducted in spinal cord injury patients. The goal of this clinical trial is to learn if rimonabant improves hand motor and performance function in patients with cervical spinal cord injury. It will also learn about the safety of rimonabant. Participants will: Take 5 mg of rimonabant every day for 90 days. Visit the clinic once every 15-30 days for checkups and tests.

Timeline

Start
2026-05-13
Primary completion
2027-08
Completion
2027-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Rimonabant Small molecule 5 mg —

Indications